Related by context. Frequent words. (Click for all words.) 68 commercialize telaprevir 65 Initiates Phase II 63 Receives Orphan Drug Designation 61 Shareholders Approve Acquisition 60 Files Shelf Registration Statement 60 NV Organon 59 Inc Therapeutic Competitors 59 CPL Biologicals 59 Announces Organizational Changes 59 Presents Positive 59 Announces FDA Clearance 58 Signs License Agreement 58 Completes Enrollment 58 gets USFDA nod 58 R sorafenib tablets 57 Finalizes Acquisition 57 Completes Tender Offer 57 CTS manufactures 57 Announces Stockholder Approval 56 Signs Licensing Agreement 56 Q1 Loss Narrows 56 CFO Exercises Options 56 Q3 Loss Narrows 56 Stockholders Approve Merger 56 ICOS Corporation 56 Meets Primary Endpoint 55 SRS Labs supports 55 Director Exercises Options 55 Further Strengthens 55 Realigns 55 SWOT Analysis companiesandmarkets.com adds 55 Strengthens Its 55 Acquires Exclusive 55 Regains Compliance 55 Vytorin combines 55 Enters Strategic 55 Expands Presence 55 Commercialize 54 Q3 Loss Widens 54 Therapeutic Competitors 54 Takeda Kyowa Hakko Kirin 54 Announces Successful Completion 54 Q2 Loss Narrows 54 GM Daewoo Holden 54 FDA Clears 54 Expands Footprint 54 Announces Initiation 54 Patent Issued 54 Bayer HealthCare subsidiary 54 BioGlue R 53 Movers Roundup 53 Signs Agreements 53 Q2 Loss Widens 53 Expands Distribution 53 strategy summarization 53 Q4 Loss Widens 53 Strengthens Leadership 53 Attains Gold Certified Partner 53 Corp. Nasdaq GENZ 53 Teijin Pharma 53 Regains Compliance With 53 Expand Presence 53 Exclusive Distributor 53 Expands Relationship 53 Explore Strategic Alternatives 53 Idec Roche 53 Releases Enhanced 53 Announces Additions 53 Extends Relationship 53 Shigamabs ® 53 Announces Presentation 53 Expand Relationship 53 Shigamabs R 53 Receives Notification 53 Announces Sponsorship 53 FDA Accepts 53 Secures Financing 53 Receives FDA Clearance 53 Provides Shareholder 53 Announce Collaboration 53 Completes Merger 53 Enters Agreement 52 Formalizes 52 strategy GlobalData summarization 52 Extends Reach 52 Files Annual Report 52 Announce Joint Venture 52 Joins OTCQX 52 Announces Definitive Agreement 52 Updates Status 52 Biodefense Division 52 Receives Regulatory 52 www.gsk.com 52 CEO Exercises Options 52 Drug Candidate 52 Announces Immediate Availability 52 Equipment Deals 52 GVAX cancer 52 Rectogesic 52 Somaxon ability 52 menopause contraception